These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 22975372)
21. A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma. Faiena I; Comin-Anduix B; Berent-Maoz B; Bot A; Zomorodian N; Sachdeva A; Said J; Cheung-Lau G; Pang J; Macabali M; Chodon T; Wang X; Cabrera P; Kaplan-Lefko P; Chamie K; Belldegrun AS; Pantuck AJ; Drakaki A J Immunother; 2020; 43(9):273-282. PubMed ID: 32925563 [TBL] [Abstract][Full Text] [Related]
22. Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction. Fonseca C; Soiffer R; Ho V; Vanneman M; Jinushi M; Ritz J; Neuberg D; Stone R; DeAngelo D; Dranoff G Blood; 2009 Feb; 113(8):1681-8. PubMed ID: 19008459 [TBL] [Abstract][Full Text] [Related]
23. Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells. Tani K; Nakazaki Y; Hase H; Takahashi K; Azuma M; Ohata J; Kitamura R; Komine F; Oiwa M; Masunaga A; Maekawa T; Satoh N; Adachi D; Soda Y; Machida U; Endo M; Yamazaki T; Watari K; Tojo A; Yamashita N; Tomikawa S; Eriguchi M; Hamada H; Wakumoto Y; Hanazawa K; Okumura K Cancer Chemother Pharmacol; 2000; 46 Suppl():S73-6. PubMed ID: 10950152 [TBL] [Abstract][Full Text] [Related]
24. Treatment of kidney cancer with autologous tumor cell vaccines of short-term cell lines derived from renal cell carcinoma. Dillman RO; Barth NM; VanderMolen LA; Garfield DH; De Leon C; O'Connor AA; Mahdavi K; Nayak SK Cancer Biother Radiopharm; 2001 Feb; 16(1):47-54. PubMed ID: 11279797 [TBL] [Abstract][Full Text] [Related]
25. Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage IV renal cell cancer in Japan: clinical and immunological findings. Tani K; Azuma M; Nakazaki Y; Oyaizu N; Hase H; Ohata J; Takahashi K; OiwaMonna M; Hanazawa K; Wakumoto Y; Kawai K; Noguchi M; Soda Y; Kunisaki R; Watari K; Takahashi S; Machida U; Satoh N; Tojo A; Maekawa T; Eriguchi M; Tomikawa S; Tahara H; Inoue Y; Yoshikawa H; Yamada Y; Iwamoto A; Hamada H; Yamashita N; Okumura K; Kakizoe T; Akaza H; Fujime M; Clift S; Ando D; Mulligan R; Asano S Mol Ther; 2004 Oct; 10(4):799-816. PubMed ID: 15451464 [TBL] [Abstract][Full Text] [Related]
27. Cellular vaccine therapies for cancer. Mastrangelo MJ; Sato T; Lattime EC; Maguire HC; Berd D Cancer Treat Res; 1998; 94():35-50. PubMed ID: 9587681 [No Abstract] [Full Text] [Related]
28. Immunotherapeutic strategies for the treatment of renal cell carcinoma: where are we now? Bedke J; Stenzl A Expert Rev Anticancer Ther; 2013 Dec; 13(12):1399-408. PubMed ID: 24215158 [TBL] [Abstract][Full Text] [Related]
29. Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma. Avigan DE; Vasir B; George DJ; Oh WK; Atkins MB; McDermott DF; Kantoff PW; Figlin RA; Vasconcelles MJ; Xu Y; Kufe D; Bukowski RM J Immunother; 2007 Oct; 30(7):749-61. PubMed ID: 17893567 [TBL] [Abstract][Full Text] [Related]
30. Immune response induced in vitro by CD16- and CD16+ monocyte-derived dendritic cells in patients with metastatic renal cell carcinoma treated with dendritic cell vaccines. Arroyo JC; Gabilondo F; Llorente L; Meraz-Ríos MA; Sánchez-Torres C J Clin Immunol; 2004 Jan; 24(1):86-96. PubMed ID: 14997038 [TBL] [Abstract][Full Text] [Related]
31. Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study. Oosterwijk-Wakka JC; Tiemessen DM; Bleumer I; de Vries IJ; Jongmans W; Adema GJ; Debruyne FM; de Mulder PH; Oosterwijk E; Mulders PF J Immunother; 2002; 25(6):500-8. PubMed ID: 12439347 [TBL] [Abstract][Full Text] [Related]
32. Next-generation peptide vaccines for advanced cancer. Yamada A; Sasada T; Noguchi M; Itoh K Cancer Sci; 2013 Jan; 104(1):15-21. PubMed ID: 23107418 [TBL] [Abstract][Full Text] [Related]